CONMED Corporation (NYSE:CNMD) Q1 2023 Results Earnings Conference Call April 27, 2023 4:30 PM ET
Company Participants
Curt Hartman - Chair of the Board, President, and Chief Executive Officer
Todd Garner - Executive Vice President and Chief Financial Officer
Conference Call Participants
Rick Wise - Stifel Financial
Lilia-Celine Lozada - J.P. Morgan
Ian Tolle - Bank of America Securities
Vik Chopra - Wells Fargo Corporate & Investment Banking
Matthew O'Brien - Piper Sandler
Mike Matson - Needham & Company
Matthew Mishan - KeyBanc Capital Markets
Young Li - Jefferies
Operator
Before the conference call begins, let me remind you that during this call management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risks and uncertainties as those are defined under the federal securities laws.
Investors are cautioned that any forward-looking statements are not guarantees of future events, performance or results. The company's actual results may differ materially from its current expectations. Please refer to the risk and other uncertainties disclosed under the forward-looking information in today's press release, as well as the company's SEC filings for more details on the risks and uncertainties that may cause actual results to differ materially. The company disclaims any obligation to update any forward-looking statements that may be disclosed during this call, except as may be required by applicable law.
You will also hear management refer to non-GAAP or adjusted measurements during this discussions. While these figures are not a substitute for GAAP measurements, management uses these figures to aid in monitoring the company's ongoing financial performance from quarter-to-quarter and year-to-year on a regular basis and from benchmarking against other medical technology companies.
Adjusted net income and adjusted earnings per share measure the income of the company, excluding credit or charges that are considered by the company to be special or outside of its normal ongoing operations. These adjusting items are specified in the reconciliation supporting the company's earnings releases posted to the company's website.
With these required announcements completed, I will turn the call over to Curt Hartman, CONMED's Chairman of the Board, President and Chief Executive Officer for opening remarks, Mr. Hartman.
Curt Hartman
Thank you, Justin. And before I dive in, the forward-looking statements comments cut in and out a little bit. So I just want to point everybody to our investor website where the presentation has been uploaded. That also includes the comprehensive forward-looking statements, in case you missed part of that opening dialogue.